Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855497) titled 'Efficacy and Safety of Second-Line Helicobacter Pylori Eradication' on Sept. 28.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Seoul National University Bundang Hospital

Condition: HELICOBACTER PYLORI INFECTIONS

Intervention: Drug: P-CAB-BM quadruple regimen

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: February 1, 2021

Target Sample Size: 141

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07855497 ...